Abstract:Background: In recent years, observational studies have provided evidence supporting a potential association between autism spectrum disorder (ASD) and gut microbiota. However, the causal effect of gut microbiota on ASD remains unknown. Methods: We identified the summary statistics of 206 gut microbiota from the MiBioGen study, and ASD data were obtained from the latest Psychiatric Genomics Consortium Genome-Wide Association Study (GWAS). We then performed Mendelian randomization (MR) to determine a causal relationship between the gut microbiota and ASD using the inverse variance weighted (IVW) method, simple mode, MR-Egger, weighted median, and weighted model. Furthermore, we used Cochran's Q test, MR-Egger intercept test, Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO), and leave-one-out analysis to identify heterogeneity and pleiotropy. Moreover, the Benjamin-Hochberg approach (FDR) was employed to assess the strength of the connection between exposure and outcome. We performed reverse MR analysis on the gut microbiota that were found to be causally associated with ASD in the forward MR analysis to examine the causal relationships. The enrichment analyses were used to analyze the biological function at last. Results: Based on the results of IVW results, genetically predicted family Prevotellaceae and genus Turicibacter had a possible positive association with ASD (IVW OR=1.14, 95% CI: 1.00-1.29, P =3.7×10 −2 ), four gut microbiota with a potential protective effect on ASD: genus Dorea (OR=0.81, 95% CI: 0.69-0.96, P =1.4×10 −2 ), genus Ruminiclostridium5 (OR=0.81, 95% CI: 0.69-0.96, P =1.5×10 −2 ), genus Ruminococcus1 (OR=0.83, 95% CI: 0.70-0.98, P =2.8×10 −2 ), and genus Sutterella (OR=0.82, 95% CI: 0.68-0.99, P =3.6×10 −2 ). After FDR multiple-testing correction we further observed that there were two gut microbiota still have significant relationship with ASD: family Prevotellaceae (IVW OR=1.24; 95% CI: 1.09-1.40, P =9.2×10 -4 ) was strongly positively correlated with ASD and genus RuminococcaceaeUCG005 (IVW OR=0.78, 95% CI: 0.67-0.89, P =6.9×10 −4 ) was strongly negatively correlated with ASD. The sensitivity analysis excluded the influence of heterogeneity and horizontal pleiotropy. Conclusion: Our findings reveal a causal association between several gut microbiomes and ASD. These results deepen our comprehension of the role of gut microbiota in ASD's pathology, providing the foothold for novel ideas and theoretical frameworks to prevent and treat this patient population in the future.

Diet, microbe, and autism: Cause or consequence?

The many faces of microbiota-gut-brain axis in autism spectrum disorder

Gut Microbiota and Autism: Key Concepts and Findings

Gut microbiota and autism spectrum disorders: a bidirectional Mendelian randomization study

Causal effects of gut microbiota on autism spectrum disorder: A two-sample mendelian randomization study

Alteration of Gut Microbiota-Associated Epitopes in Children with Autism Spectrum Disorders

The Gut Microbiota and Autism Spectrum Disorders

Gut microbiome and serum amino acid metabolome alterations in autism spectrum disorder

New insights on gut microbiome and autism

The Human Gut Microbiome as a Potential Factor in Autism Spectrum Disorder

Revealing the gut microbiome mystery: A meta-analysis revealing differences between individuals with autism spectrum disorder and neurotypical children

Analysis of gut microbiota profiles and microbe-disease associations in children with autism spectrum disorders in China

Microbiome-Specific Statistical Modeling Identifies Interplay Between Gastrointestinal Microbiome and Neurobehavioral Outcomes in Patients With Autism: A Case Control Study

Role of the Gut Microbiota in the Pathophysiology of Autism Spectrum Disorder: Clinical and Preclinical Evidence

The Influence of Food Intake Specificity in Children with Autism on Gut Microbiota

Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder

The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder

Dietary flavonoids modulate the gut microbiota: A new perspective on improving autism spectrum disorder through the gut-brain axis

Potential of gut microbiome for detection of autism spectrum disorder

Alteration of the gut microbiota profile in children with autism spectrum disorder in China

Changes in the Gut Microbiota of Children with Autism Spectrum Disorder